Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 May;112(1):75–80. doi: 10.1111/j.1476-5381.1994.tb13032.x

The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion.

L McMurdo 1, C Thiemermann 1, J R Vane 1
PMCID: PMC1910309  PMID: 8032665

Abstract

1. The effects were investigated of the ETA receptor antagonist, FR 139317, on endothelin-1 (ET-1)-induced coronary vasoconstriction in the isolated perfused heart of the rabbit. In addition, this study examined whether FR 139317 reduced infarct size in a rabbit model of coronary artery occlusion and reperfusion. 2. In the rabbit isolated perfused heart, ET-1 (1-100 pmol) elicited a dose-dependent increase in coronary perfusion pressure (CPP). For example, 30 pmol ET-1 caused CPP to rise by 22 +/- 8 mmHg and 100 pmol ET-1 by 47 +/- 10 mmHg (n = 8). Infusion of FR 139317 (1 microM) significantly attenuated the increase in CPP caused by ET-1 (30 pmol: 3 +/- 1 mmHg, 100 pmol: 8 +/- 2 mmHg; n = 8). 3. In the anaesthetized rabbit, infarct size (expressed as a percentage of the area at risk) after 45 or 60 min of coronary artery occlusion followed by 2 h of reperfusion was 47 +/- 6% (n = 6) and 55 +/- 7% (n = 5), respectively. A continuous infusion of FR 139317 (0.2 mg kg-1 min-1 preceded by a loading dose of 1.0 mg kg-1, i.v.; n = 5-6) had no effect on the extent of the myocardial infarct size (45 min: 47 +/- 6%; 60 min: 49 +/- 7%).(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
78

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990 Dec 20;348(6303):730–732. doi: 10.1038/348730a0. [DOI] [PubMed] [Google Scholar]
  2. Baydoun A. R., Peers S. H., Cirino G., Woodward B. Effects of endothelin-1 on the rat isolated heart. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S193–S196. doi: 10.1097/00005344-198900135-00054. [DOI] [PubMed] [Google Scholar]
  3. Bigaud M., Pelton J. T. Discrimination between ETA- and ETB-receptor-mediated effects of endothelin-1 and [Ala1,3,11,15]endothelin-1 by BQ-123 in the anaesthetized rat. Br J Pharmacol. 1992 Dec;107(4):912–918. doi: 10.1111/j.1476-5381.1992.tb13385.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brunner F., du Toit E. F., Opie L. H. Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts. J Mol Cell Cardiol. 1992 Nov;24(11):1291–1305. doi: 10.1016/0022-2828(92)93095-2. [DOI] [PubMed] [Google Scholar]
  5. Chester A. H., Dashwood M. R., Clarke J. G., Larkin S. W., Davies G. J., Tadjkarimi S., Maseri A., Yacoub M. H. Influence of endothelin on human coronary arteries and localization of its binding sites. Am J Cardiol. 1989 Jun 1;63(18):1395–1398. doi: 10.1016/0002-9149(89)91055-2. [DOI] [PubMed] [Google Scholar]
  6. Chiariello M., Golino P., Cappelli-Bigazzi M., Ambrosio G., Tritto I., Salvatore M. Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion. Am Heart J. 1988 Mar;115(3):499–504. doi: 10.1016/0002-8703(88)90796-x. [DOI] [PubMed] [Google Scholar]
  7. Clarke J. G., Benjamin N., Larkin S. W., Webb D. J., Davies G. J., Maseri A. Endothelin is a potent long-lasting vasoconstrictor in men. Am J Physiol. 1989 Dec;257(6 Pt 2):H2033–H2035. doi: 10.1152/ajpheart.1989.257.6.H2033. [DOI] [PubMed] [Google Scholar]
  8. Clozel J. P., Clozel M. Effects of endothelin on the coronary vascular bed in open-chest dogs. Circ Res. 1989 Nov;65(5):1193–1200. doi: 10.1161/01.res.65.5.1193. [DOI] [PubMed] [Google Scholar]
  9. Douglas S. A., Elliott J. D., Ohlstein E. H. Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responses. Eur J Pharmacol. 1992 Oct 20;221(2-3):315–324. doi: 10.1016/0014-2999(92)90718-j. [DOI] [PubMed] [Google Scholar]
  10. Ezra D., Goldstein R. E., Czaja J. F., Feuerstein G. Z. Lethal ischemia due to intracoronary endothelin in pigs. Am J Physiol. 1989 Jul;257(1 Pt 2):H339–H343. doi: 10.1152/ajpheart.1989.257.1.H339. [DOI] [PubMed] [Google Scholar]
  11. Flores N. A., Davies R. L., Penny W. J., Sheridan D. J. Coronary microangiography in the guinea pig, rabbit and ferret. Int J Cardiol. 1984 Oct;6(4):459–471. doi: 10.1016/0167-5273(84)90326-7. [DOI] [PubMed] [Google Scholar]
  12. Grover G. J., Sleph P. G., Fox M., Trippodo N. C. Role of endothelin-1 and big endothelin-1 in modulating coronary vascular tone, contractile function and severity of ischemia in rat hearts. J Pharmacol Exp Ther. 1992 Dec;263(3):1074–1082. [PubMed] [Google Scholar]
  13. Hirata K., Matsuda Y., Akita H., Yokoyama M., Fukuzaki H. Myocardial ischaemia induced by endothelin in the intact rabbit: angiographic analysis. Cardiovasc Res. 1990 Nov;24(11):879–883. doi: 10.1093/cvr/24.11.879. [DOI] [PubMed] [Google Scholar]
  14. Larkin S. W., Clarke J. G., Keogh B. E., Araujo L., Rhodes C., Davies G. J., Taylor K. M., Maseri A. Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol. 1989 Oct 15;64(14):956–958. doi: 10.1016/0002-9149(89)90855-2. [DOI] [PubMed] [Google Scholar]
  15. Lidbury P. S., Cirillo R., Vane J. R. Dissociation of the anti-ischaemic effects of cloricromene from its anti-platelet activity. Br J Pharmacol. 1993 Sep;110(1):275–280. doi: 10.1111/j.1476-5381.1993.tb13805.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lindner V., Heinle H. Binding properties of circulating Evans blue in rabbits as determined by disc electrophoresis. Atherosclerosis. 1982 Jun;43(2-3):417–422. doi: 10.1016/0021-9150(82)90040-5. [DOI] [PubMed] [Google Scholar]
  17. Liu J., Chen R., Casley D. J., Nayler W. G. Ischemia and reperfusion increase 125I-labeled endothelin-1 binding in rat cardiac membranes. Am J Physiol. 1990 Mar;258(3 Pt 2):H829–H835. doi: 10.1152/ajpheart.1990.258.3.H829. [DOI] [PubMed] [Google Scholar]
  18. Maxwell M. P., Hearse D. J., Yellon D. M. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res. 1987 Oct;21(10):737–746. doi: 10.1093/cvr/21.10.737. [DOI] [PubMed] [Google Scholar]
  19. McMurdo L., Lidbury P. S., Thiemermann C., Vane J. R. Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor. Br J Pharmacol. 1993 Jun;109(2):530–534. doi: 10.1111/j.1476-5381.1993.tb13602.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Miyauchi T., Yanagisawa M., Tomizawa T., Sugishita Y., Suzuki N., Fujino M., Ajisaka R., Goto K., Masaki T. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet. 1989 Jul 1;2(8653):53–54. doi: 10.1016/s0140-6736(89)90303-6. [DOI] [PubMed] [Google Scholar]
  21. Moreland S., McMullen D. M., Delaney C. L., Lee V. G., Hunt J. T. Venous smooth muscle contains vasoconstrictor ETB-like receptors. Biochem Biophys Res Commun. 1992 Apr 15;184(1):100–106. doi: 10.1016/0006-291x(92)91163-k. [DOI] [PubMed] [Google Scholar]
  22. NACHLAS M. M., SHNITKA T. K. Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Am J Pathol. 1963 Apr;42:379–405. [PMC free article] [PubMed] [Google Scholar]
  23. Neubauer S., Ertl G., Haas U., Pulzer F., Kochsiek K. Effects of endothelin-1 in isolated perfused rat heart. J Cardiovasc Pharmacol. 1990 Jul;16(1):1–8. doi: 10.1097/00005344-199007000-00001. [DOI] [PubMed] [Google Scholar]
  24. Neubauer S., Ertl G., Pulzer F., Haas U., Hirsch A., Zimmermann S., Kochsiek K. Effects of endothelin-1 in the isolated heart under ischemic and cardioplegic conditions. J Cardiovasc Pharmacol. 1990 Nov;16(5):804–811. doi: 10.1097/00005344-199011000-00017. [DOI] [PubMed] [Google Scholar]
  25. Neubauer S., Zimmermann S., Hirsch A., Pulzer F., Tian R., Bauer W., Bauer B., Ertl G. Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injury. J Mol Cell Cardiol. 1991 Dec;23(12):1397–1409. doi: 10.1016/0022-2828(91)90186-p. [DOI] [PubMed] [Google Scholar]
  26. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990 Dec 20;348(6303):732–735. doi: 10.1038/348732a0. [DOI] [PubMed] [Google Scholar]
  27. Salminen K., Tikkanen I., Saijonmaa O., Nieminen M., Fyhrquist F., Frick M. H. Modulation of coronary tone in acute myocardial infarction by endothelin. Lancet. 1989 Sep 23;2(8665):747–747. doi: 10.1016/s0140-6736(89)90813-1. [DOI] [PubMed] [Google Scholar]
  28. Sogabe K., Nirei H., Shoubo M., Nomoto A., Ao S., Notsu Y., Ono T. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist. J Pharmacol Exp Ther. 1993 Mar;264(3):1040–1046. [PubMed] [Google Scholar]
  29. Thiemermann C., Thomas G. R., Vane J. R. Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion. Br J Pharmacol. 1989 Jun;97(2):401–408. doi: 10.1111/j.1476-5381.1989.tb11967.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Watanabe T., Suzuki N., Shimamoto N., Fujino M., Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res. 1991 Aug;69(2):370–377. doi: 10.1161/01.res.69.2.370. [DOI] [PubMed] [Google Scholar]
  31. Watts J. A., Chapat S., Johnson D. E., Janis R. A. Effects of nisoldipine upon vasoconstrictor responses and binding of endothelin-1 in ischemic and reperfused rat hearts. J Cardiovasc Pharmacol. 1992 Jun;19(6):929–936. doi: 10.1097/00005344-199206000-00014. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES